🔉 Did tinnitus loudness improve?
None shown.
No convincing percept-level data.
Transcutaneous auricular VNS (taVNS) for Tinnitus: What Does the Evidence Show?
Neuromodulation
Current evidence
Non-surgical vagus nerve stimulation via an ear clip — small pilots so far; larger sham-controlled trials are registered but none has reported.
Evidence strength: Limited (2/5) · Tier 3 — experimental/emerging · Evidence independence: Primarily independent.
Electrical stimulation of the vagus nerve's auricular branch through a clip on the tragus/concha, alone or paired with sound (e.g., notched music) — the non-invasive cousin of the implanted paired-VNS approach. Cheap consumer ear-clip stimulators are already sold online.
Did tinnitus loudness or distress improve?
🧠 Did tinnitus distress improve?
Limited.
Systematic reviews (2023) find only small heterogeneous pilots — insufficient evidence.
Loudness means the tinnitus percept itself became quieter (psychoacoustic matching or loudness ratings). Distress means questionnaire scores such as THI/TFI, sleep, anxiety or quality of life improved — the sound may be unchanged. A THI/TFI improvement is never evidence the tinnitus got quieter.
How strong is the evidence?
Plausible mechanism, pilots only: 2/5 until a larger sham-controlled trial reports.
What the studies found 1 tracked
Transcutaneous auricular vagus nerve stimulation for tinnitus: systematic review with meta-analysis
Fernández-Hernando D, et al. · Journal of Clinical Medicine · 2023 · N=Small heterogeneous pilots · Systematic review with meta-analysis (4 studies pooled)
Pooled meta-analysis of 4 studies found a statistically positive effect on tinnitus disability of LOW CLINICAL RELEVANCE; underlying studies small and heterogeneous; evidence insufficient for practice.
A multicenter double-blind RCT of taVNS + notched music (Sun Yat-Sen, NCT05417711) is the first adequately sized test.
What are the limitations?
- Only small heterogeneous pilots published
- Consumer devices sold well ahead of the evidence
Has the result been independently replicated?
Limited independent. Small pilots from different groups; pooled effect of low clinical relevance.
What should patients know about safety?
Safety evidence: Strong. Generally well tolerated; local skin irritation; consumer devices vary in quality.
Is it available?
Regulatory status: Investigational for tinnitus; consumer devices unregulated. No FDA clearance/authorization for tinnitus. Sun Yat-Sen Memorial Hospital registered a double-blind RCT of taVNS + notched music (NCT05417711; registry status unknown, not updated since 2023) and a larger successor (NCT07794462: 444 planned; real vs sham taVNS, with notched music in both groups — so it tests taVNS, not notched music itself; not yet recruiting; planned completion 2030). The successor’s main outcome is a composite ‘effective rate’, not a validated tinnitus questionnaire.
Availability: Consumer tVNS gadgets sold online (unvalidated) · Europe: Same · Cost (approx.): $100–500 consumer devices
Related clinical trials 1
- taVNS paired with tailor-made notched music (double-blind RCT) — Unknown status (verified at ClinicalTrials.gov 2026-09-25)
Tracked trials are research in progress, not recommended treatments.
Related treatments 5
- Auricle bisensory stimulation (Susan Shore device) — One of the strongest randomized results for making the tinnitus sound itself quieter — still stuck in the lab.
- Lenire (bimodal tongue stimulation) — Pairs sound with mild tongue stimulation — the first and only device of its type the FDA has authorized for…
- Paired vagus nerve stimulation (VNS) — A promising pilot, then silence — the sponsor took the technology to stroke rehab instead.
- Neosensory Duo (wristband bimodal) — A consumer wristband borrowing the bimodal idea — sold on one small company-run study.
- Acoustic coordinated reset (Desyncra) — An elegant theory whose confirmatory trial came back empty.
Claim checks that mention this treatment
From Tinnitus Claims: Fact vs. Evidence, which checks popular claims against the research. It does not change this treatment’s evidence rating.
Evidence last reviewed: 2026-09-04 · Evidence included through: 2026-09-04 · Confidence: moderate. Open the interactive evidence profile · How we rate evidence.
This page summarizes published research for education. It is not medical advice; it cannot say what will work for any individual. Discuss treatment decisions with a qualified clinician.